On March 30 2023, Kalorama Information indicates that the global IVD market is now over $124 billion, with operations in more than 20 key healthcare and medical areas, such as infectious disease immunoassays, POC, molecular microbiology, clinical chemistry, etc. It also predicts that over the next 5-10 years, IVD manufacturers should capture the following 3 major trends:

 

1) The IVD industry in developed countries is growing slowly, while the IVD industry in developing countries maintains high growth;

2) In developing countries, the focus should be on infectious diseases and chronic diseases worldwide. The prevalence of cancer, heart disease and autoimmune diseases has increased.

3) As privatization of healthcare services increases around the world, both in developed countries and in emerging economies, the pricing pressure for all devices (including IVD instruments) increases.

 

The global infectious disease diagnostic testing market is expected to be approximately $45.7 billion in 2031, growing at a CAGR of approximately 4.7% from 2018, according to "Infectious Disease Diagnostic Testing: World Market Analysis" by Kalorama Information. The report states that the infectious disease diagnostic testing market is growing at the same rate as the global IVD market, and it will account for more than 38% of the IVD market in the next 10 years.

Segment Market Size of Infectious Disease Diagnostic Testing

1. TORCH: including Toxoplasma gondii, cytomegalovirus, rubella virus, HSV-1, HSV-2, and microvirus B19, etc.

2. STIs: including Chlamydia, HPV, gonorrhea, HSV-2, syphilis, etc.

3. Influenza: Influenza virus

4. HAIs

 

5. HIV/AIDS

6. Hepatitis

7. Tuberculosis

8. ID / AST

9. Other Infections: including RSV, Emerging, neglected, and tropical disease threats, Lyme Disease, Fungal Disease, Parasitic Disease, Dengue fever, Malaria, etc.